Malaria may be on the retreat, but it still kills one African child every minute, so it’s unsurprising that Elisabeth Braw’s article on the biotech company breeding sterile male mosquitoes for release in malaria-affected areas hit the top spot on GSB’s business and development hub this year.
Other popular stories in 2014 include Randall Krantz’s feature on the south Asian country famed for its Gross National Happiness index, Oliver Balch on the day charity Global Witness pushed Shell to explain more about its “shadowy deals” with Nigeria’s former oil minister, and Jo Confino on the need for Nissan to withdraw a dangerous car model from the Indian market.
1. Genetically engineered mosquitoes could be vital weapon against malaria
An Oxford-based biotech firm is modifying the males of the species to be sterile, effectively making the killers kill themselves
2. India’s new CSR law sparks debate among NGOs and businesses
India is the first country to mandate a minimum spend on corporate social responsibility initiatives. In a country facing multiple socio-economic challenges – can it work?
3. Nissan called on to withdraw dangerous car model from Indian market
Car assessment body NCAP calls on Nissan to withdraw the Datsun GO, pending an urgent redesign, after it was awarded zero stars for tests of its most basic safety features
4. Shell is pushed to explain its role in $1.1bn Nigerian corruption scandal
The British-Dutch group paid a huge fee to develop an offshore oil block. Wherever the money ended up, the loser is Nigeria
5. Bhutan is not all about happiness; it’s a country grappling with modernity
The Kingdom’s gross national happiness approach to development has been successful, but it still faces challenges. A robust private sector can help
Get involved!
Let us know what your most memorable business and development story was in 2014. Tweet us @GuardianSustBiz with #GSB2014. To get in touch with ideas for business in development coverage in 2015, email jennifer.kho@theguardian.com
The role of business in development hub is funded by Business Call to Action. All content is editorially independent except for pieces labelled ‘brought to you by’. Find out more here.
This content is brought to you by Guardian Professional. Become a GSB member to get more stories like this direct to your inbox.
